VTRS · 8-K · 20261008PR039024

Pain Pipeline Development

Viatris Inc · 2026-10-08 · Importance 25 · Surprise 24

Pacira’s clinical-stage pipeline includes assets for musculoskeletal pain and related therapeutic areas. Its lead candidate, PCRX-201 (enekinragene inzadenovec), is a locally administered gene therapy in Phase 2 development for osteoarthritis of the knee. Viatris said the acquisition would add an innovative development pipeline in specialty-driven areas of high unmet need.

Key facts

• The acquisition adds an innovative development pipeline in high-value, specialty-driven therapeutic areas with high unmet need. source